Register Now

NATCO Pharma gets 7 observations from FDA for Hyderabad manufacturing unit

The inspection was conducted over 10 days, from June 9-19, 2025. Shares of NATCO Pharma Ltd ended at ₹881.35, up by ₹3.75, or 0.43%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *